Cart
sales@molnova.com
Pongamol
CAS No. 484-33-3
Pongamol( —— )
Catalog No. M24437 CAS No. 484-33-3
Pongamol, an identified lead molecule from the fruits of Pongamia pinnata, on glucose uptake and GLUT4 translocation in skeletal muscle cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 37 | In Stock |
|
| 25MG | 59 | In Stock |
|
| 50MG | 86 | In Stock |
|
| 100MG | 125 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePongamol
-
NoteResearch use only, not for human use.
-
Brief DescriptionPongamol, an identified lead molecule from the fruits of Pongamia pinnata, on glucose uptake and GLUT4 translocation in skeletal muscle cells.
-
DescriptionPongamol, an identified lead molecule from the fruits of Pongamia pinnata, on glucose uptake and GLUT4 translocation in skeletal muscle cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number484-33-3
-
Formula Weight294.3
-
Molecular FormulaC18H14O4
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO=C(C1=CC=C(OC=C2)C2=C1OC)CC(C3=CC=CC=C3)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tamrakar AK, Jaiswal N, Yadav PP, Maurya R, Srivastava AK. Pongamol from Pongamia pinnata stimulates glucose uptake by increasing surface GLUT4 level in skeletal muscle cells. Mol Cell Endocrinol. 2011;339(1-2):98-104. doi:10.1016/j.mce.2011.03.023
molnova catalog
related products
-
Arctiin
Arctiin(NSC 315527), a plant lignan that can be extracted from the Arctium lappa (burdock) seeds, is a possible environmental endocrine disruptor compound and have been shown to influence sex hormone metabolism as well as protein synthesis, steroid biosynthesis.
-
Opromazine hydrochlo...
Opromazine hydrochloride is a compound used as a molecular building block.
-
RMC-6291
RMC-6291 is an orally active, covalent inhibitor of KRAS G12C (ON) that forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA), thereby preventing KRAS G12C (ON) from signaling via steric blockade of RAS effector binding and eliciting deep and durable suppression of RAS pathway activity in KRAS G12C tumor models .
